AbbVie | ABBV - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
AbbVie USD 33.3B 29.71B 2026-06
Abbott USD 4.68B 439M 2026-03
ALKERMES USD 107.69M 35.17M 2026-09
Amgen USD 20.83B 17.97B 2026-09
AstraZeneca USD 23.57B 679M 2026-09
Biogen USD 430.3M 26.4M 2026-09
BioMarin Pharmaceutical USD 946.11M 32.44M 2026-09
Bristol-Myers Squibb USD 4.63B 470M 2026-09
Coherus Biosciences USD 13.17M 1.69M 2026-06
Eisai JPY 81.67B 5.86B 2026-09
Eli Lilly USD 5.79B 319M 2026-09
Gilead Sciences USD 934M 260M 2026-09
GlaxoSmithKline GBP 15.63B 1.29B 2026-09
J&J USD 9.32B 94M 2026-09
Medtronic USD 2.7B 51M 2026-06
Merck USD 5.03B 1.2B 2026-09
Neurocrine Biosciences USD 754.1M 612.1M 2026-09
Novartis USD 4.24B 15M 2026-09
Pacira USD 17.5M 4K 2026-09
Perrigo USD 390.5M 9.9M 2026-09
Pfizer USD 4.07B 511M 2026-09
Regeneron Pharmaceuticals USD 1.14B 19M 2026-09
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 24.55B 957M 2026-09
UCB EUR 4.04B 755M 2025-12
Ultragenyx Pharmaceutical USD 45M 6M 2026-09
United Therapeutics USD 520.2M 22.4M 2026-09
Vertex Pharmaceuticals USD 3.71B 99.2M 2026-09
Zoetis USD 419M 33M 2026-09